*Staphylococcus aureus* is a major human pathogen that elicits wide range of exotoxins that are responsible for diverse disease symptoms in humans. Some *S. aureus* exotoxic proteins are pyrogenic, which includes staphylococcal enterotoxins (SETs) and toxic shock syndrome toxin 1 (TSST-1)[@b1]. Among the diseases caused by *S. aureus,* staphylococcal food poisoning is one of the most commonly exploded food-borne illnesses in humans that results from the consumption of foods contaminated with staphylococcal enterotoxins (SETs). SETs, with diverse serotypes, cause various types of disease symptoms to human globally[@b2].

Staphylococcal enterotoxin B (SEB) is one of the most frequently existing toxin serotypes in staphylococcal food poisoning[@b3][@b4]. SEB is a 28-kDa-protein superantigen and one of the most potent mitogens reported. The biological effects of super-antigens include pyrogenicity, enhancement of lethal endotoxin shock, and induction of inflammatory cytokines, such as tumor necrosis factor and interleukin1[@b5]. SEB mediates its biological effects by binding to the major histocompatibility complex (MHC) class II at a different site and is distinct from other antigens in that it does not have to be preprocessed. SEB is a protein with no potential for high mortality, but its high emetic potency (LD~50~ - 0.02 mgkg^−1^) and fast action (2 to 8 h) raised an interest as devastating agent[@b6]. The toxin is especially attractive as a biological warfare agent because much lower quantities of SEB (LD~50~ value- 0.02 mgkg^−1^ by both the inhalational and the intravenous routes) were needed than of synthetic chemicals to produce intoxicating effects in humans and ease of bulk production. Besides, they are potent gastrointestinal exotoxins, resistant to proteolytic enzymes, high temperature (upto 100 °C), and extreme pH values owing to their compact tertiary structures, which will be retained even after enzymatic activities in the digestive tract[@b7]. Hence it is currently listed as a category B select Bio-weapon agent[@b8].

It is therefore implied that there is an urgent need to develop cost effective, rapid, accurate, and reliable diagnostic methods for sensitive detection of SEB from contaminated food and environmental samples as well as therapeutic strategies to protect public health against SEB. Nearly sixty-eight methods based on antibodies and analytical instrumentation, including surface plasmon resonance[@b9], piezoelectric crystal immunosensing[@b10], magnetoelastic sensing[@b11], liquid chromatography mass spectrometry[@b12], surface-enhanced Raman scattering probe[@b13], cantilever sensing[@b14], electrochemical[@b15] and photonic crystal lab-on-a-chip methods[@b16] are already available for the detection of SEB. These reported methods have their own limitations such as requirement of expertise personnel for data interpretation, sophisticated instrumentation, lengthy protocol times, and diseconomy. Also most of these methods depend either directly or indirectly on antibodies against target agent. However, these antibodies are sensitive to temperature and pH alterations, and also have limited lifetimes. Moreover, there are still several other problems in the production of antibodies against toxic proteins, such as batch to batch variations in polyclonal antibody development, stringent regulations in animal ethical committee approvals to handle large number of animals or high cost involvement in maintaining hybridoma cell lines for bulk production of monoclonal antibodies[@b17]. Besides all the above limitations, interference of staphylococcal protein A (spA) is most important issue in diagnostic development against staphylococcal entrotoxins. SpA is a protein displayed by *S. aureus* on the cell surface and also released outside and it strongly binds to all IgG produced in mammals. Therefore, the antibodies when used for the detection of any toxin of *S. aureus* will produce false positive results. Hence, it is still a great challenge to create new ideas and strategies for the development of a simple to use reliable, rapid and low-cost detection systems which can be adopted to resource-poor settings in developing countries to overcome the problems associated with SEB.

Recently aptamers and chicken antibodies (IgY) have attracted significant attention of researchers over existing high-cost and conventional antibody based approaches to detect target threat agents. Aptamers are single stranded DNA/RNA (ssDNA or RNA) molecules, which possess high recognition ability toward specific targets and have a potential application as bio-probes for targeted drug delivery and bio-sensing applications[@b18][@b19]. Aptamers have many advantages over antibodies, such as more stable, easier modification, easier synthesis, and higher affinity, and they can be fluorescently labeled and do not require experimental animals for synthesis[@b20][@b21]. Due to these properties, a variety of aptamer-based analytical methods including electrochemistry, fluorescence, atomic force microscope, and quartz crystal microbalance have been developed for molecular recognition and detection of threat agents[@b22][@b23][@b24][@b25].

Due to the utility of two different bio-ligands raised against same target molecule, sandwich immunoassays play a crucial role in sensitive and selective detection of target toxic agents like SEB. In development of sandwich immunoassays for detection of SEB, utility of IgY is great advantage, since IgY is free from interaction with protein A, which is major obstacle in development of SEB detection systems[@b26]. Moreover, ease of production in bulk quantities, moderate sensitivities and high specificities together with free from animal ethical committee issues makes it significance to be a better alternative over monoclonal as well as polyclonal antibodies. Till date utilization of IgY for development SEB detection systems are scanty[@b27]. Hence, sensitive immunoassays continue to provide a more realistic alternative for detection of SEB from food and environmental samples are needed.

In the present study, we developed such a system, based on sandwich immunoassay, in which IgY as a capture agent and single strand biotinylated DNA aptamer as a reveling probe. To evaluate the reliability and ease of access, developed method was evaluated onto several food and clinical samples originated from India were undertaken and results of the developed method showed very promising for detection of SEB in tested samples.

Results
=======

Cloning of recombinant SEB
--------------------------

In order to prepare recombinant SEB toxin that could facilitate SELEX process for ssDNA aptamer generation, we cloned full length of SEB toxin encoding gene into pET22 (b+) expression vector and the cloning strategy was followed as shown in [Fig. 1A](#f1){ref-type="fig"}. Care has been taken during designing of primers for amplification of SEB to accommodate open reading frame of the vector as well as C-terminal histidine tag encoding sequence existing in vector. After successful cloning, the expression host *E. coli* BL21 DE3 colonies transformed with desired gene was recovered and sub cloned on to LB agar medium with suitable antibiotics as well as same was inoculated into LB broth. Plasmid extraction was performed from transformed *E. coli* BL21 DE3 colonies and was sequenced to check the sequence similarity with the native gene sequence of SEB before conducting the expression analysis.

Expression and purification of recombinant SEB
----------------------------------------------

The presence of full length recombinant SEB toxin from expression host *E. coli* BL21 DE3 harboring pET22 (b+) SEB vector was analyzed by SDS-PAGE after 5 hours induction with 1.5, 1 and 0.5 mM IPTG concentrations at 28 °C ([Fig. 1B](#f1){ref-type="fig"}) and was confirmed by western-blotting analysis using anti Histidine antibodies ([Fig. 1C](#f1){ref-type="fig"}). It was found to be 1 mM concentration of IPTG for 5 hrs induction at 28 °C showed significant expression compared with uninduced control cells. The SDS-PAGE and western-blotting analysis revealed that a 28 KD recombinant SEB was expressed by host cells and was purified by Ni-NTA affinity chromatography. The bulk expression of rSEB was performed in 500 ml LB broth from which, we could achieve protein yield of 15.4 mg. The purified protein fractions after affinity chromatography were pooled and dialyzed against 1X PBS for 72 h with 3 buffer changes to remove excess salts.

Selection of ssDNA aptamers against SEB
---------------------------------------

Using rSEB toxin as a coating antigen, ssDNA aptamers were generated from randomized DNA library with known 5′ and 3′ over hangs. After 8 rounds of SELEX process, we obtained the highly specific ssDNA aptamers against the target antigen. Out of 7 aptamers obtained which were generated against the antigen ([Table 1B](#t1){ref-type="table"}), SEB-1 and SEB-2 were found highly specific to the target and rest were shown low sensitivity with nonspecific interactions with other toxins. Hence present study was conducted with SEB-1 and SEB-2 aptamers for ALISA method development and selected aptamer secondary structures were represented in [Fig. 2](#f2){ref-type="fig"}.

Generation, characterization and purification of IgY
----------------------------------------------------

The chickens were immunized five times in 10 days intervals to elicit good immune response. At the end of fifth immunization, blood was collected from the chicken to determine the antibody response. When the end point titer of immunized chickens was found to be 1:32,000, then eggs were collected to extract the IgY antibodies. A total of 20 eggs were collected from each bird. Each egg could yield about 3 mg of antibodies and from all the eggs, we could achieve 60 mg of anti-SEB IgY antibodies as determined by Lowry's protein estimation. The precipitated antibodies were found to be pure and not contaminated with any other components of egg yolk as confirmed by SDS-PAGE (results not shown).

Specificity of the aptamer and IgY
----------------------------------

The specificity of the aptamers for rSEB was evaluated by dot ELISA in which other related protein toxins such as SEA, SEC, TSST and a-hemolysin were coated. Results showed that, selected aptamers reacted exclusively with SEB toxin with no cross reactivity to the other related protein toxins were found ([Fig. 3A](#f3){ref-type="fig"}). Similarly, cross reactivity of anti SEB-IgY was also evaluated by indirect plate ELISA and results showed that, anti-SEB-IgY was highly reactive to SEB toxin than the other studied toxins. However, some cross reactivity was observed with SEC and SEA. But, interestingly there was no cross reactivity with protein-A which, present in *S. aureus* and common interference during ELISA reactions with antibodies ([Fig. 3B](#f3){ref-type="fig"}). By employing these bio-ligands (anti-SEB-Aptamer and IgY) in the present study, we developed a sandwich dot-ALISA method was robust and low cost detection of SEB as well to avoid the residual cross reactivity of Protein A of *Staphylococcus* spp., thus to freed from false positive results in the diagnostic assay.

Sandwich-dot-ALISA for cost effective detection of SEB
------------------------------------------------------

After success full characterization of generated bioligands including anti SEB-IgY and anti SEB apatmers, a simple to use cost effective dot-ALSIA method was standardized for detection of SEB from food and other contaminated samples. The schematic representation of the sandwich ALISA is depicted in [Fig. 4](#f4){ref-type="fig"}. Developed method was further characterized in terms of sensitivity, specificity and reliability.

Sensitivity of sandwich dot ALISA
---------------------------------

The sensitivity of the aptamers and anti-SEB antibodies were first compared and evaluated prior to the development of sandwich dot ELISA. Initially, aptamer and IgY were tested at various concentrations against 100 ng of antigen (SEB) per spot. The aptamer could display the colored spot at 250 ngmL^−1^ concentration whereas the IgY could develop color at 500 ng mL^−1^ concentration and the sensitivity of the aptamer was stayed as twofold higher than the IgY antibody. Hence these concentrations were chosen for the assay development. Similarly evaluation of the aptamer and IgY at 250 ng mL^−1^ and 500 ngmL^−1^, respectively was performed with various concentrations of the antigen ranging from 10 μgmL^−1^ to 0.01 μgmL^−1^. It was deduced that the aptamer at 250 ngmL^−1^ concentration could detect 25 ng ml^−1^ of target antigen (SEB), where as IgY antibodies at 500 ngmL^−1^ concentration could able to detect 50 ngmL^−1^ of SEB. Moreover, as determined IgY was showed some cross reactivity with other enterotoxins as well, hence we decided to use IgY as capturing molecule and aptamer as revealing probe in the sandwich dot-ALISA method. Upon development of hybrid sandwich-ALISA method, it was tested on various concentrations of the toxin and we found that developed method was able to detect 50 ngmL^−1^ of target antigen as revealed by IgY capture antibody ([Fig. 5A,B](#f5){ref-type="fig"}). We further evaluated the same matrix with microtitre plate format onto various toxigenic and non toxigenic strains of *S. aureus* and other related bacteria and study results revealed that, developed method was highly specific to the SEB toxin alone ([Fig. 6](#f6){ref-type="fig"}).

Evaluation of sandwich dot-ALISA onto natural samples
-----------------------------------------------------

Further the ALISA method was tested on the contaminated food and environmental samples. All the samples contaminated with *S. aureus* positive for SEB have displayed brick-red dots in dot-ALISA ([Fig. 7](#f7){ref-type="fig"}). These samples were also verified by PCR for SEB gene and the developed dot-ALISA method results were consistent with PCR assay for SEB encoding gene ([Table 1](#t1){ref-type="table"}).

Discussion
==========

*Staphylococcus aureu*s is one of the most important pathogenic organisms posing greatest threats in clinical infections. The pathogen is unique and notorious owing to its range of infection missiles viz., α-hemolysin, several enterotoxins (as many as 23, ranging from SEA to SHV), TSST and other secretary proteins. As if insufficient, it is also rapidly gaining resistance for most of the antibiotics. Among its defensive mechanisms, SEB forms the most important one because of several reasons such as (a) most potent toxin capable of crossing gastro-intestinal barrier; (b) possible to aerosolize the toxin which also implies that SEB can be made into biological weapon; (c) ingestion of even at nanogram levels cause staphylococcal infections in children and (d) enterotoxins are heat resistant. Hence, there is plethora of literature available dealing with the detection of SEB from various substances such as food, clinical and suspected samples. Among these detection methods, antibody based methods such as immuno affinity assay (Luminex), lateral flow systems and ELISAs and nucleic acid based methods such as PCRs, real time PCRs, dot blots are available. And several advanced immunoassays developed such as Semiconductor Nanocrystal Immunoassays[@b28], Western blotting[@b29], SET-RPLA kits, sandwich ELISAs[@b30][@b31] and chemiluminescence enzyme immunoassay[@b32] which were highly specific to SEB.

Immuno based systems are found to be more convenient, cost effective and robust than conventional nucleic acid based methods for toxin detection because conventional nucleic acid assays demand additional steps of sample purification and the sensitivity will be easily compromised by interfering substances such as cell debris, media components or other substances. Therefore, in the preset study, we generated the anti-SEB bio-ligands including, IgYs and ssDNA aptamers that were shown to be high reactive and specific towards SEB. With the use of these bi-ligand molecules, we were able to develop sandwich hybrid system for cost effective, rapid and sensitive detection of SEB from contaminated food and clinical samples. In particular, the system was able to detect SEB at 50 ngmL^−1^ level from contaminated food matrix, which is far beyond the proposed LD~50~ limits of the SEB to humans. SpA is a cell wall associated protein present in nearly all strains of *S. aureus*. It is also secreted into the culture supernatant during exponential phase. SpA binds to Fc region of all the major classes of mammalian immunoglobulins and produce false positives during immunoassays[@b33]. In a previous study comparing Vidas SET2 to Transia plate SET detection kits, all test samples were submitted to a protein extraction step and pretreatment with non-immunized rabbit plasma to avoid possible interference by protein A[@b34]. In the case of Vidas SET2, a specific treatment for removing the Fc fragment from IgG was used to avoid any interference by protein A. Recent reports reveal that the incubation in DEPC for 10 min inhibits binding of SpA to both capture antibody in sandwich ELISA and detecting antibody in Western blotting procedures[@b35]. Though DEPC treatment is effective in blocking SpA binding to mammalian IgG to great extent, there are certain setbacks like DEPC also interferes with binding of specific antibodies with antigens of *S. aureus* because it can modify amino acid residues such as histidine, lysine, tyrosine, serine and threonine which may be present in the antigen binding paratopes thus reducing the sensitivity of the assay[@b36].

Another suitable alternative thus explored was to develop IgY antibodies from chicken eggs. It is relatively cheaper, less painful to the animals and avoids costly hybridoma. Earlier reports also agree that the involvement of IgY instead of IgG eliminated SpA interference in immunoassays[@b27][@b37]. Some earlier studies have reported that IgY is not a suitable molecule for capturing antigens since its flexibility at the hinge region is restricted[@b37]. But many workers have successfully utilized IgY for capturing the antigens[@b27][@b28]. Besides, production of monoclonal antibodies from mice which is most explored and widely popular the main limitation is that the generation and their characterization are time and resource intensive. It also demands technical expertise in hybridoma technology. In the present study too we could efficiently employ IgY as capturing molecule. In our study, without any pretreatment of samples, anti-rSEB IgY, as expected, did not react with protein A. The samples were directly added to the NC membrane precoated with capturing molecule.

For revealing probes, we developed aptamers specific to SEB by SELEX method. Earlier, several workers have employed ssDNA aptamers for the detection of SEB. The first ssDNA aptamer to SEB was reported by Bruno *et al.* in 2002[@b38]. Later Purschke *et al.* discovered spiegelmer ssDNA aptamer which was promising[@b39]. However, these aptamers were never tested for their specificity towards SEB against other toxins. Later, ssDNA aptamers were reported by DeGrasse designated APT^SEB1^, found to be specific to SEB even in the presence of mixture of other SEs[@b40]. Apart from these reports, very little work has progressed in the development of DNA aptamers against SEB toxin. Besides, aptamers are more flexible and able to configure around the antigen firmly. Aptamers are very versatile molecules for utilization in detection systems in comparison to antibodies as aptamers are equally specific to the target and also achieve similar sensitivity as monoclonal antibodies but the production of aptamers are easy, cost effective and able disseminate the sequence information that allow other scientists to replicate to suit their needs (Zhijiang *et al.*, 2014)[@b40][@b41]. However, antibodies are more suitable for capturing the target molecules from different matrices than aptamers as the antibodies possess structural rigidity that is not disturbed by chemicals and other interfering substances present in the source substances. Combining the advantages of both aptamers and IgY, in the present study, we focused on development of sandwich immuno and aptamer based dot ELISA platform. To our knowledge, this is the first report describing a novel sandwich ELISA involving DNA aptamers and chick antibodies for the detection of SEB.

Materials & Methods
===================

Chemicals, media and reagents
-----------------------------

All the salts and bacteriological media were purchased from Himedia Labs, India, except mentioned specifically. The aptamer library, primers and biotinylated probes were synthesized at 1 mM and 250 nM scale, respectively at IDT, USA. The stock and working dilutions of the library and the primers were maintained in milliQ water.

Preparation of recombinant SEB (rSEB) protein
---------------------------------------------

The full length SEB encoding gene from *S. aureus* ATCC 51740 was amplified by standard PCR protocol. Primers of SEB gene were designed to insert *Bgl II* and *Hind III* sites at 5′ and 3′ ends respectively. The primer sequences Ent (F) --GGA*AGATCT*ACCAGATCCTAAACCAGATG and Ent B (R) -- TAG*AAGCTT*GTTTGTCAGTTTGATGCG representing forward and reverse primers, respectively were used to amplify the *SEB* gene[@b42]. Construction of *SEB-pET22B* vector was carried out by standard cloning procedure described by Sambrook *et al.* (2001)[@b43]. Briefly, PCR amplified product was purified and restriction digestion was carried out with appropriate restriction enzymes. Simultaneously, *pET22B* vector DNA was also digested with the same enzymes. Digested products were purified by gel extraction kit (Sigma, USA) and ligation was performed using T4 DNA ligase kit (Promega, Germany) at 4 °C for overnight. Ligation was confirmed by PCR with T7 promoter primers and the cloned vector was transformed into expression host, *E. coli* BL21(DE3) competent cells (Invitrogen, USA). The positive clones were confirmed by colony PCR using T7 promoter primers. Expression optimization of recombinant protein SEB (rSEB) was undertaken using IPTG induction. Native form of expressed rSEB was purified from *E. coli* host cells by Ni-NTA affinity chromatography (Qiagen, Germany) following manufacturer's instructions (Qiaexpressionist). The purified fractions of rSEB was dialyzed against 1X PBS for 72 h at 4 °C with 3 buffer changes and confirmed by SDS-PAGE and Western-blotting analysis using anti-SEB polysera (Sigma, India).

Selection of ssDNA aptamers against SEB by SELEX method
-------------------------------------------------------

The ssDNA aptamer library used in the present study consists of a central region of 40 randomized nucleotides flanked 22 bases forward and 25 bases of reverse primer binding regions necessary for PCR amplification ([Table 1A](#t1){ref-type="table"}).

SELEX method
============

Purified rSEB was coated onto microtiter 96 well ELISA plate at 1 μg per well in 50 mM coating buffer (50 mM carbonate and bio-carbonate buffer, pH-9.4) and incubated for 60 min at room temperature (RT), followed by blocking the unbound spaces in wells with 5% defatted milk solution for 2 h at 42 °C. The SELEX method was performed as per the protocol by Pan *et al.*, (2010)[@b44] and complete protocol of SELEX method was given in Supplementary methods section-2. A total of 8 rounds of SELEX were performed and after 5^th^ round of SELEX procedure noncompetitive SELEX was done using protein A, SEC, SEA and TSST toxins (kindly provided by Prakash Narayana Reddy, CFTRI, Mysore) until the specific ssDNA aptamer sequence against SEB was obtained. After 8 rounds of SELX protocol, we achieved a pool of ssDNA aptamers reactive only against rSEB. Highly reactive pool was cloned into TA cloning vector and sequenced (Xcelris Genomics, Ahmedabad, India). The ssDNA aptamer sequences were used to predict the structure and KD values by M-fold software tool.

Specificity & sensitivity evaluation
------------------------------------

The specificity and sensitivity of the aptamers developed in this study were determined by dot ELISA method as described elsewhere for antibodies with suitable modifications[@b45]. Briefly, the selected aptamers were amplified in bulk by PCR using the primers for the flanked regions with the biotinylated reverse primer. Different toxins secreted by *S. aureus* such as SEA, SEC, TSST, α-hemolysin and protein A along with rSEB protein were coated onto nitrocellulose membrane at a concentration of 50 μgmL^−1^. The rSEB toxin was used as the positive control and PBS as a negative control. After coating, the membrane was blocked with 5% milk solution at 45 °C for 1 h. Then, the membrane was incubated for 60 min at room temperature (RT) with ssDNA aptamer dissolved in binding buffer (5 mM Tris--HCl with 1 M NaCl, pH 7.5). Following this, the membrane was stringently washed with PBST to remove the nonspecific binding of aptamer molecules and then incubated with Streptavidin-HRP conjugate (Sigma, USA) for 30 min at room temperature. The unbound HRP-streptavidin was washed off thoroughly with PBST and coloring substrate TMB-H~2~O~2~ (Aristogene Biosciences, Bengaluru, India) (1X) solution and 3,3′,5,5′-diamine benzidine tetrahydrochloride (DAB) (Sigma, India) were added. The color development was observed and documented. The colorimetric reaction was stopped by rinsing the membrane in tap water.

Similarly, the sensitivity of the ssDNA aptamer was determined by applying a series of rSEB dilutions ranging from 10 μg to 10 ng on to nitrocellulose membrane followed by dot-ELISA as mentioned above.

Animal Ethical Statement
------------------------

The animal experiment was reviewed and approved by the Institutional Animal Ethical Committee (Letter No. UOM/IAEC/13/2012; Dated 10-11-2012) University of Mysore, Mysore. Animal handling and experiments were carried out in accordance with the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA).

Generation and characterization of anti SEB-IgY antibodies
==========================================================

Immunization of chicken with rSEB toxin
---------------------------------------

White leghorn chickens were purchased from the authorized suppliers (Suguna, Coimbatore, India). The birds were brought to the facility and checked for the presence of anti-SEB IgY with the pre immunized serum by indirect-ELISA method before immunization[@b27]. After negative confirmation, the fowls were immunized intramuscularly (i.m.) with 100 μg of rSEB emulsified with equal volumes of Freunds complete adjuvant under the breast muscles. After 14 days of priming, booster immunizations were administered with 100 μg of the protein with equal amount of Incomplete Freund's adjuvant at 12 day intervals. At the end of fifth immunization, the eggs were collected and checked for antibody titer by indirect ELISA against rSEB.

Purification of chicken IgY antibodies from egg
-----------------------------------------------

After attaining the desired immune-reactivity (1:12,000), IgY was purified from immunized chicken eggs by PEG precipitation method[@b46]. In brief, the collected egg yolks were mixed with equal volumes of PBS containing 0.01% NaN~3~, followed by addition of PEG6000 at a final concentration of 3.5% (V/V). Then the content was mixed vigorously and centrifuged at 13,000 × g for 10 min and the supernatant was collected. To this, PEG was added to a final concentration of 8.5% and then centrifuged. After centrifugation, pellet was dissolved in equal volume of PBS and precipitated with 12% PEG. The pellet was separated after centrifugation and redissolved in PBS. The purity and concentration IgY was determined by SDS-PAGE and Lowry's protein estimation method, respectively.

Specificity and Sensitivity evaluation of anti-SEB-IgY
------------------------------------------------------

The reactivity of IgY with SEB and the other toxins produced by *S. aureus* such as SEA, SEC, TSST and a-hemolysin was determined by indirect-ELISA method[@b27].

Development of IgY-aptamer based sandwich dot ELISA against SEB
---------------------------------------------------------------

In the present study, a novel IgY-aptamer sandwich ELISA was developed for specific and sensitive detection of SEB. Anti-SEB IgY antibodies and ssDNA aptamer-biotin probe were used as the capturing and the revealing probes for SEB, respectively. Sandwich ELISA protocol was followed as per the previous reports of Reddy *et al.*, (2013) with minor changes[@b27]. In the present study, we employed ssDNA aptamer as the revealing probe instead of rabbit anti SEB antibodies.

Specificity and sensitivity evaluation of sandwich dot ELISA
------------------------------------------------------------

To check the specificity, the developed method was evaluated onto a series of toxigenic and notoxigenic *S. aureus* and other species of *staphylococcus* as well as other bacterial genera including *E. coli, Salmonella, Shigella* isolated from food and environmental sources ([Table 2](#t2){ref-type="table"}). Sensitivity of the developed method was evaluated on to purified SEB toxin collected from enterotoxigenic *S. aureus* (ATCC-14458).

Purification of SEB
-------------------

*Staphylococcus aureus* (ATCC-14458) capable of producing enterotoxin B (SEB) was purchased from ATCC, USA. Pure colony of *S. aureus* was inoculated in 100 mL BHI broth and grown overnight at 37 °C under shaking at 175 rpm. The following day, the supernatant was collected by centrifuging the cells at 12,000 rpm for 3 min. The SEB toxin was extracted by methanol-chloroform method followed by standard protein precipitation protocols.

Evaluation of sandwich dot ELISA on natural samples
---------------------------------------------------

To check the reliability, usability and readability, the developed method was evaluated onto naturally contaminated samples from food and clinical centers of India were included in the present study ([Table 3](#t3){ref-type="table"}). These field samples were subjected to enrichment in BHI broth for 4 h at 37 °C prior to sandwich indirect plate-ALISA and dot-ALISA. The present method was compared with standard PCR method for SEB.
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![Cloning, expression and purification of recombinant SEB.\
**(A)** Cloning strategy of recombinant SEB gene into pET22B (+) expression vector. (**B**) SDS-PAGE showing expression of rSEB toxin (M- Unstained protein ladder); 1,2 and 3- Lysates of *E. coli BL21DE3* cells induced with 1.5, 1 and 0.5 mM IPTG respectively; 4- Uninduced *E. coli BL21DE3* cell lysate). (**C**) Western blot analysis showing rSEB toxin expression (M- Prestained protein ladder; 1 and 2 Induced cell lysates of *E. coli BL21DE3*; 4- Uninduced *E. coli BL21DE3* cell lysate. Cell lysates probed with HRP- tagged anti His antibodies.](srep15151-f1){#f1}

![Secondary structure prediction of selected anti-SEB-Aptamers.](srep15151-f2){#f2}

![Specificity evaluation of anti SEB-aptamer (**A**) and anti anti-SEB-IgY (**B**).\
(**A**) 1 and 2 replicates of the assay; SEA- Staphylococcal Enter toxin A; SEC- Staphylococcal Enter toxin C; SEB- Staphylococcal Enter toxin B; TSST- Toxic Shock Syndrome Toxin; HLA- α-Hemolysin. Different toxins (1 μgmL^−1^) of *S. aureus* were coated onto nitro cellulose membrane and probed with biotinylated anti SEB aptamer. (**B**) **SEB**- Staphylococcal Enter toxin B; **SEC**-Staphylococcal Enter toxin C; **SEA**- Staphylococcal Enter toxin A; **TSST**- Toxic Shock Syndrome Toxin; **HLA**- α-Hemolysin. Different toxins (1 μgmL^−1^) of *S. aureus* were coated onto microtitre plate wells and probed with anti SEB-IgY.](srep15151-f3){#f3}

![Schematic representation of IgY sandwich-ALISA.](srep15151-f4){#f4}

![Sensitivity determination of sandwich ALISA against pure SEB toxin.\
(**A**) Sandwich dot-ELISA; (**B**) Sandwich plate ELISA. (**A**) SEB toxin was added to IgY pre-coated nitro cellulose membrane at following concentrations A- 10 μgmL^−1^; B- 5 μgmL^−1^; C- 1 μgmL^−1^; D- 0.5 μgmL^−1^; E- 0.25 μgmL^−1^; F- 0.1 μgmL^−1^; G- 0.05 μgmL^−1^; H- 0.01 μgmL^−1^ and then SEB toxin was probed with biotinylated anti SEB aptamer. LOD of the assay was determined as 50 ngmL^−1^. (**B**) Various concentrations of SEB were added to IgY pre-coated microtiter plate wells. The indirect ALISA was performed using biotinylated anti SEB aptamer. For blank control PBS was used. The graph shows average ± SD of the absorbance reading in independent triplicates.](srep15151-f5){#f5}

![Specificity of sandwich plate-ALISA onto different culture supernatants.\
Enriched culture supernatants of various strains of *S. aureus* and other food borne bacterial pathogens were added to IgY pre-coated microtitre plate wells and the toxin bound was probed with biotinylated anti SEB aptamer. For blank control PBS was used. The absorbance values shown in figure denoted average ± SD of the independent triplicates.](srep15151-f6){#f6}

![Evaluation of IgY Sandwich ALISA on to filed samples.\
1: CK01, 2: CK06, 3: CK07, 4: MK03, 5: MK04, 6: MT02, 7: CL01, 8: CL03, 9: CL07, 10: CL08, 11: *S. aureus* NCIM-2079, 12: *S. aureus* NCIM-2079, 13: *S. aureus* NCIM-2654, 14: *S. aureus* NCIM-2657, 15: *S. aureus* NCIM-5021, P: SEB toxin (50 ngml^−1^), N: SEC toxin (50 ngml^−1^). The enriched culture supernatants were added to anti-SEB-IgY pre-coated nitrocellulose membrane strips and the toxin bound was probed with biotinylated anti-SEB-aptamer.](srep15151-f7){#f7}

###### Primers used for Aptamer selection and selected Aptamer sequences after different rounds of SELEX.

  A. Primers used for Aptamer selection                                                                                                                                           
  ------------------------------------------------------------ ------------------------------------------------------------------------------------------------- ----------- ---- ------
  SelexAPLIB2                                                      ATAGGAGTCACGACGACCAGAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTATGTGCGTCT ACCTCTTGACTAAT        1 μmole    87   HPLC
  Apta F1 N                                                                                         ATAGGAGTCACGACGACCAGAA                                        250 nmole   22   DST
  Apta R1 N                                                                                        ATTAGTCAAGAGGTAGACGCACATA                                      250 nmole   25   DST
  Apt BIO For                                                                                    5Biosg/ATAGGAGTCACGACGACCAGAA                                    250 nmole   22   HPLC
  Apt Bio Rev                                                                                  5Biosg/ATTAGTCAAGAGGTAGACGCACATA                                   250 nmole   25   HPLC
  Selected Aptamer sequences after different rounds of SELEX                                                                                                                      
  SEB 1                                                         ATAGGAGTCACGACGACCAGAA [CTCGTGTCGTTGTAGTCTGTTGTCAGTTCTGATCTATGCA]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 2                                                         ATAGGAGTCACGACGACCAGAA [AATGCTATGATGCTAGTAGCAGTAGCGTAGCAGTCGAATT]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 3                                                         ATAGGAGTCACGACGACCAGAA [TACGTCATAAGTTGCTAGTCACATGAATAATTAATATCGT]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 4                                                         ATAGGAGTCACGACGACCAGAA [CTGTATAATTACTAGTATGTAATGATTAATCTATGATGCG]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 5                                                         ATAGGAGTCACGACGACCAGAA [ATCTAGAGCATCATGAGTGTCAGTAGACATAGTCATGATA]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 6                                                         ATAGGAGTCACGACGACCAGAA [CAGTTGACCAGCTTAGATTTTTAACCAAAGGATTTTACCA]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   
  SEB 7                                                         ATAGGAGTCACGACGACCAGAA [TGCATTTAACGGATAAATTTAGCCAGCGGCATTTAGTCAG]{.ul} ATGTGCGTCTACCTCTTGACTAAT                   

###### Comparative detection of SEB harboring strains by PCR and IgY-sandwich ALISA.

  List of standard strains                                                                  
  -------------------------- -------------------------------------- ------------------ ---- ----
  01                          *Staphylococcus. aureus* ATCC-700699      ATCC, USA       \+   \+
  02                                 *S. aureus* ATCC-29213             ATCC, USA       \+   \+
  03                                 *S. aureus* NCIM-2079             NCIM, India      \+   \+
  04                                 *S. aureus* NCIM-2654             NCIM, India      \+   \+
  05                                 *S. aureus* NCIM-2657             NCIM, India      \+   \+
  06                                 *S. aureus* NCIM-5021             NCIM, India      \+   \+
  07                          *S. aureus* ATCC-19095(SEC positive)      ATCC, USA       −    −
  08                            *S. aureus* E-2167(SEE positive)     Clinical isolate   −    −
  09                              *S. epidermidis* ATCC-12228           ATCC, USA       −    −
  10                          *Salmonella typhimurium* ATCC-14028       ATCC, USA       −    −
  11                              *Bacillus cereus* ATCC-10876          ATCC, USA       −    −
  12                               *Shigellaboydii* ATCC-9207           ATCC, USA       −    −
  13                             *Escherichia coli* ATCC-10536          ATCC, USA       −    −
  14                           *Klebsiella pneumonia* ATCC-10031        ATCC, USA       −    −

ATCC --- American Type Culture Collection, Manassas, VA, USA.

NCIM --- National Collection of Industrial Organisms, Pune, India.

###### Enriched field samples.

  Sl. No.          Source          PCR   IgY-sandwich ALISA
  --------- --------------------- ----- --------------------
  01           Cake isolate 01     \+            \+
  02           Cake isolate 03      −            −
  03           Cake isolate 06     \+            \+
  04           Cake isolate 07     \+            \+
  05           Milk isolate 01      −            −
  06           Milk isolate 03     \+            \+
  07           Milk isolate 04     \+            \+
  08           Milk isolate 05      −            −
  09           Meat isolate 01      −            −
  10           Meat isolate 02     \+            \+
  11           Meat isolate 04      −            −
  12         Clinical isolate 01   \+            \+
  13         Clinical isolate 03   \+            \+
  14         Clinical isolate 04   \+            \+
  15         Clinical isolate 05    −            −
  16         Clinical isolate 07   \+            \+
  17         Clinical isolate 08   \+            \+
